Vietnamese Government issues resolution on COVID-19 vaccine purchase, use
	People involved in anti-pandemic mission are a priority for Covid-19 vaccination
	Made-in-Vietnam Covid-19 vaccine enters second phase of human trials

Vingroup granted a COVID-19 aid package worthing VND 20 billion (US $866,618) to IVAC (Photo: Nguoi Lao Dong)

Duong Huu Thai, director of Nha Trang Institute of Vaccines and Medical Biologicals, announced the expected price Saturday morning. “Hopefully Covivac’s human trials will soon have good results so that Vietnamese residents would have an affordable, yet effective COVID-19 vaccine”, Thai was quoted by Nguoi Lao Dong.

Vingroup – Vietnam’s biggest conglomerate – on February 27 morning had granted a COVID-19 aid package worthing VND 20 billion (US $866,618) to the Institute of Vaccines and Medical Biologicals (IVAC).

“Vietnam has gone through unprecedented difficulties in the fight against COVID-19 over the past year. Having enough vaccines on hand is crucial for the new normal life. This is a challenging task, but Vietnam has done a good job in speeding COVID-19 vaccine development”, Health Minister Nguyen Thanh Long said at the ceremony. “Nonocovax vaccine of Nanogen Company has already entered the second phase of human trials”.

Long emphasized that the Health Ministry had been expediting local vaccine development as well as negotiating to order more imported vaccines. Vaccination must start at the earliest time given the potential dangers of the new variants.

“I believe Vietnam’s vaccine development would be promising”, he said.

Duong Huu Thai, director of Nha Trang Institute of Vaccines and Medical Biologicals (Photo: Nguoi Lao Dong)

The Covivac vaccine is the research work of the Institute of Vaccines and Medical Biologicals (IVAC) under the Ministry of Health (MOH). It had earlier yielded safe results and strong immunity responses on mice, rabbits, etc. Given promising results on animals, the vaccine is granted to enter human trials starting January, two months earlier than expected.

“If all three trial phases yield good results, Vietnam might have the vaccine in late 2021”, Thai said. “IVAC has an edge in the production process thanks to its available infrastructure, technology, and decade-long experience in producing flu vaccines”, Dr. Duong Huu Thai, Director of IVAC said.

Meanwhile, Nanogen’s Nanocovax which has just entered the second human trial is priced at VND120,000 ($5.17) per dose. Along with injections, Vietnam’s COVID-19 Nanocovax vaccine will also be developed in the form of eye-drop and nasal spray for special subjects.

Along with this, two other made-in-Vietnam vaccine candidates produced by Vabiotech and Polyvac are currently evaluating their vaccines on animals, having completed the laboratory-scale production process.

Covivac vaccine (Photo: VOV)

Vietnam’s COVID-19 vaccine proves effective on new variants The locally-made Covivac vaccine is said to have triggered high immunity response against new Covid-19 variants emerging in the world, but further studies are still ...

Determining Vietnam’s COVID-19 vaccine position on world’s vaccine map? While the number of new COVID-19 infections and death tolls keeps growing, the need to churn out vaccines against the virus has become more urgent ...

Vietnam's second COVID-19 vaccine set to enter human trials this month IVAC's Covivac COVID-19 vaccine will enter human trials in January after safety test assessments in animals, becoming the second vaccine in Vietnam to granted such ...